Listed

Fate Therapeutics Inc

FATENasdaqCIK 1434316HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$2.1m, Q2 FY2026
Operating income−$31.1m, Q2 FY2026
Net income−$30.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m1.9Revenue, Q3 FY2023, three months to 2023-09-30$1.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figure1.7Revenue, Q4 FY2023, three months to 2023-12-31$1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-05, accession 0000950170-25-033510. Derived: 12-month figure less the 9-month figure.Report this figure1.9Revenue, Q1 FY2024, three months to 2024-03-31$1.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure6.8Revenue, Q2 FY2024, three months to 2024-06-30$6.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0000950170-25-107309.Report this figure3.1Revenue, Q3 FY2024, three months to 2024-09-30$3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure1.9Revenue, Q4 FY2024, three months to 2024-12-31$1.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure1.6Revenue, Q1 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure1.9Revenue, Q2 FY2025, three months to 2025-06-30$1.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure1.7Revenue, Q3 FY2025, three months to 2025-09-30$1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure1.4Revenue, Q4 FY2025, three months to 2025-12-31$1.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure1.3Revenue, Q1 FY2026, three months to 2026-03-31$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure2.1Revenue, Q2 FY2026, three months to 2026-06-30$2.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure
Research and development$m34.3Research and development, Q3 FY2023, three months to 2023-09-30$34.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figure31.8Research and development, Q4 FY2023, three months to 2023-12-31$31.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-05, accession 0000950170-25-033510. Derived: 12-month figure less the 9-month figure.Report this figure32.1Research and development, Q1 FY2024, three months to 2024-03-31$32.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure34.6Research and development, Q2 FY2024, three months to 2024-06-30$34.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107309.Report this figure34.7Research and development, Q3 FY2024, three months to 2024-09-30$34.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure33.6Research and development, Q4 FY2024, three months to 2024-12-31$33.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure29.1Research and development, Q1 FY2025, three months to 2025-03-31$29.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure27.4Research and development, Q2 FY2025, three months to 2025-06-30$27.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure25.8Research and development, Q3 FY2025, three months to 2025-09-30$25.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure25.4Research and development, Q4 FY2025, three months to 2025-12-31$25.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure24.7Research and development, Q1 FY2026, three months to 2026-03-31$24.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure24.4Research and development, Q2 FY2026, three months to 2026-06-30$24.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure
Operating income$m(51.3)Operating income, Q3 FY2023, three months to 2023-09-30−$51.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figure(48.1)Operating income, Q4 FY2023, three months to 2023-12-31−$48.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-05, accession 0000950170-25-033510. Derived: 12-month figure less the 9-month figure.Report this figure(51.1)Operating income, Q1 FY2024, three months to 2024-03-31−$51.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure(45.1)Operating income, Q2 FY2024, three months to 2024-06-30−$45.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107309.Report this figure(52.4)Operating income, Q3 FY2024, three months to 2024-09-30−$52.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure(61.7)Operating income, Q4 FY2024, three months to 2024-12-31−$61.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure(41.3)Operating income, Q1 FY2025, three months to 2025-03-31−$41.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure(37.0)Operating income, Q2 FY2025, three months to 2025-06-30−$37.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure(34.7)Operating income, Q3 FY2025, three months to 2025-09-30−$34.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure(34.7)Operating income, Q4 FY2025, three months to 2025-12-31−$34.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure(33.0)Operating income, Q1 FY2026, three months to 2026-03-31−$33.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure(31.1)Operating income, Q2 FY2026, three months to 2026-06-30−$31.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(45.2)Net income, Q3 FY2023, three months to 2023-09-30−$45.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figure(44.1)Net income, Q4 FY2023, three months to 2023-12-31−$44.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-05, accession 0000950170-25-033510. Derived: 12-month figure less the 9-month figure.Report this figure(48.0)Net income, Q1 FY2024, three months to 2024-03-31−$48.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure(38.4)Net income, Q2 FY2024, three months to 2024-06-30−$38.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure(47.7)Net income, Q3 FY2024, three months to 2024-09-30−$47.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure(52.2)Net income, Q4 FY2024, three months to 2024-12-31−$52.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure(37.6)Net income, Q1 FY2025, three months to 2025-03-31−$37.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure(34.1)Net income, Q2 FY2025, three months to 2025-06-30−$34.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure(32.3)Net income, Q3 FY2025, three months to 2025-09-30−$32.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure(32.4)Net income, Q4 FY2025, three months to 2025-12-31−$32.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure(31.2)Net income, Q1 FY2026, three months to 2026-03-31−$31.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure(30.2)Net income, Q2 FY2026, three months to 2026-06-30−$30.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure
Diluted EPS$ per share(0.46)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figurenot reported(0.47)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure(0.33)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-107309.Report this figure(0.40)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figurenot reported(0.32)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure(0.29)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure(0.27)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figurenot reported(0.26)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure(0.25)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure
Basic EPS$ per share(0.46)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figurenot reported(0.47)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure(0.33)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-107309.Report this figure(0.40)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figurenot reported(0.32)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure(0.29)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure(0.27)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figurenot reported(0.26)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure(0.25)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure

Balance sheet

Cash and equivalents$32.4m, Q2 FY2026
Shareholders' equity$153.4m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m33.3Cash and equivalents, Q3 FY2023, at 2023-09-30$33.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figure41.9Cash and equivalents, FY2023, at 2023-12-31$41.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-05, accession 0000950170-25-033510.Report this figure121Cash and equivalents, Q1 FY2024, at 2024-03-31$121.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure36.9Cash and equivalents, Q2 FY2024, at 2024-06-30$36.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107309.Report this figure37.9Cash and equivalents, Q3 FY2024, at 2024-09-30$37.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure36.1Cash and equivalents, FY2024, at 2024-12-31$36.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-073699.Report this figure44.9Cash and equivalents, Q1 FY2025, at 2025-03-31$44.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure41.2Cash and equivalents, Q2 FY2025, at 2025-06-30$41.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure40.6Cash and equivalents, Q3 FY2025, at 2025-09-30$40.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure46.6Cash and equivalents, FY2025, at 2025-12-31$46.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure39.6Cash and equivalents, Q1 FY2026, at 2026-03-31$39.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure32.4Cash and equivalents, Q2 FY2026, at 2026-06-30$32.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure
Current assets$m364Current assets, Q3 FY2023, at 2023-09-30$364.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061080.Report this figure332Current assets, FY2023, at 2023-12-31$331.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-05, accession 0000950170-25-033510.Report this figure394Current assets, Q1 FY2024, at 2024-03-31$394.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056869.Report this figure319Current assets, Q2 FY2024, at 2024-06-30$319.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096187.Report this figure310Current assets, Q3 FY2024, at 2024-09-30$310.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figure292Current assets, FY2024, at 2024-12-31$291.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-073699.Report this figure248Current assets, Q1 FY2025, at 2025-03-31$248.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure230Current assets, Q2 FY2025, at 2025-06-30$230.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107309.Report this figure221Current assets, Q3 FY2025, at 2025-09-30$221.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure209Current assets, FY2025, at 2025-12-31$208.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure180Current assets, Q1 FY2026, at 2026-03-31$179.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure158Current assets, Q2 FY2026, at 2026-06-30$158.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure
Total assets$m544Total assets, Q3 FY2023, at 2023-09-30$543.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061080.Report this figure506Total assets, FY2023, at 2023-12-31$506.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-05, accession 0000950170-25-033510.Report this figure570Total assets, Q1 FY2024, at 2024-03-31$569.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056869.Report this figure529Total assets, Q2 FY2024, at 2024-06-30$528.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-096187.Report this figure495Total assets, Q3 FY2024, at 2024-09-30$495.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figure441Total assets, FY2024, at 2024-12-31$440.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-073699.Report this figure399Total assets, Q1 FY2025, at 2025-03-31$398.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure372Total assets, Q2 FY2025, at 2025-06-30$371.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107309.Report this figure344Total assets, Q3 FY2025, at 2025-09-30$343.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure319Total assets, FY2025, at 2025-12-31$318.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure285Total assets, Q1 FY2026, at 2026-03-31$284.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure260Total assets, Q2 FY2026, at 2026-06-30$260.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure
Current liabilities$m41.3Current liabilities, Q3 FY2023, at 2023-09-30$41.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061080.Report this figure39.1Current liabilities, FY2023, at 2023-12-31$39.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-05, accession 0000950170-25-033510.Report this figure45.4Current liabilities, Q1 FY2024, at 2024-03-31$45.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056869.Report this figure34.8Current liabilities, Q2 FY2024, at 2024-06-30$34.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096187.Report this figure37.4Current liabilities, Q3 FY2024, at 2024-09-30$37.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figure38.5Current liabilities, FY2024, at 2024-12-31$38.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-073699.Report this figure28.2Current liabilities, Q1 FY2025, at 2025-03-31$28.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure28.7Current liabilities, Q2 FY2025, at 2025-06-30$28.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107309.Report this figure28.1Current liabilities, Q3 FY2025, at 2025-09-30$28.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure36.1Current liabilities, FY2025, at 2025-12-31$36.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure30.7Current liabilities, Q1 FY2026, at 2026-03-31$30.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure32.6Current liabilities, Q2 FY2026, at 2026-06-30$32.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m403Shareholders' equity, Q3 FY2023, at 2023-09-30$402.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figure368Shareholders' equity, FY2023, at 2023-12-31$368.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-073699.Report this figure426Shareholders' equity, Q1 FY2024, at 2024-03-31$426.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure397Shareholders' equity, Q2 FY2024, at 2024-06-30$397.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure362Shareholders' equity, Q3 FY2024, at 2024-09-30$362.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure319Shareholders' equity, FY2024, at 2024-12-31$318.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure288Shareholders' equity, Q1 FY2025, at 2025-03-31$288.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure261Shareholders' equity, Q2 FY2025, at 2025-06-30$261.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure234Shareholders' equity, Q3 FY2025, at 2025-09-30$234.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure207Shareholders' equity, FY2025, at 2025-12-31$207.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure180Shareholders' equity, Q1 FY2026, at 2026-03-31$179.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure153Shareholders' equity, Q2 FY2026, at 2026-06-30$153.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure

Cash flow

Operating cash flow−$23.4m, Q2 FY2026
Capital expenditure$80.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(38.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$38.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125317. Derived: 9-month figure less the 6-month figure.Report this figure(36.6)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$36.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-05, accession 0000950170-25-033510. Derived: 12-month figure less the 9-month figure.Report this figure(33.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$33.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure(32.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$32.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107309. Derived: 6-month figure less the 3-month figure.Report this figure(29.4)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$29.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-279096. Derived: 9-month figure less the 6-month figure.Report this figure(27.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$27.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure(33.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$33.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure(24.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$24.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-347988. Derived: 6-month figure less the 3-month figure.Report this figure(24.4)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$24.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-279096. Derived: 9-month figure less the 6-month figure.Report this figure(23.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$23.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure(30.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$30.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure(23.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$23.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure
Capital expenditure$m0.6Capital expenditure, Q3 FY2023, three months to 2023-09-30$565.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125317. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$181.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-05, accession 0000950170-25-033510. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$86.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$51.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-107309. Derived: 6-month figure less the 3-month figure.Report this figure0.5Capital expenditure, Q3 FY2024, three months to 2024-09-30$495.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-279096. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$98.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure1.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure1.4Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-347988. Derived: 6-month figure less the 3-month figure.Report this figure2.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$2.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-279096. Derived: 9-month figure less the 6-month figure.Report this figure1.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-073699. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$239.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$80.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-347988. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)120.40m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares97.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3097,023,506 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061080.Report this figure98.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3198,054,687 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056869.Report this figure98.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3098,400,355 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096187.Report this figure98.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3098,568,012 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125317.Report this figure101Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31101,104,345 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-070285.Report this figure117Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30117,468,124 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-107309.Report this figure118Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30117,769,161 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure118Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31118,375,540 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure119Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30118,528,046 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure119Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30118,998,693 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-279096.Report this figure120Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31120,030,638 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-220696.Report this figure120Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30120,397,390 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure

Shares outstanding: 119.82mShares outstanding, period not labelled, at 2026-08-06119,820,514 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347988.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.